FindTrial
Sign In

Study the Methods for treating and boosting the immune system in diabetic foot ulcer patients.

Treatment modalities and immune response in patients with Diabetic Foot Ulcers. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/063190
Enrollment
50
Registered
2024-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Control Intervention1: Topical enzyme dressing: Topical enzyme containing papain/urea (prolyse/debridace/autolyse)

Sponsors

Dr D Y Patil Vidyapeeth
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients with k/c/o DM, with foot lesions suspected to be a DFU attending OPDs & IPD patients at Dr D. Y. Patil Medical College, Hospital & Research Centre, Pimpri, Pune- 411018(Maharashtra) India. (Patients with diabetes mellitus –as defined by World Health Organisation (WHO)

Exclusion criteria

Exclusion criteria: Patients with more than or equal to Grade 2 Wagner classification of diabetic ulcers

Design outcomes

Primary

MeasureTime frame
Healing of diabetic foot ulcersTimepoint: 4 weeks—

Secondary

MeasureTime frame
Improvement in cell mediated immune responseTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr Srikanth Tripathy

Dr D Y Patil Medical College Hospital and Research Centre Dr D Y Patil Vidyapeeth Pimpri

director.medicalresearch@dpu.edu.in9500779797

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026